Alam Jahangir
VA Palo Alto Health Care System(US)
Publications by Year
Research Areas
Legal and Regulatory Analysis, Linguistic, Cultural, and Literary Studies, Military Technology and Strategies, Cytokine Signaling Pathways and Interactions, Pharmacological Receptor Mechanisms and Effects
Most-Cited Works
- → RO1138452 and RO3244794: characterization of structurally distinct, potent and selective IP (prostacyclin) receptor antagonists(2005)96 cited
- → 3-Amido Pyrrolopyrazine JAK Kinase Inhibitors: Development of a JAK3 vs JAK1 Selective Inhibitor and Evaluation in Cellular and in Vivo Models(2012)66 cited
- → Identification and SAR of novel diaminopyrimidines. Part 1: The discovery of RO-4, a dual P2X3/P2X2/3 antagonist for the treatment of pain(2009)62 cited
- → Identification and SAR of novel diaminopyrimidines. Part 2: The discovery of RO-51, a potent and selective, dual P2X3/P2X2/3 antagonist for the treatment of pain(2009)49 cited
- → Discovery and SAR development of 2-(phenylamino) imidazolines as postacyclin receptor antagonists(2004)47 cited
- → Discovery of novel brain permeable and G protein-biased beta-1 adrenergic receptor partial agonists for the treatment of neurocognitive disorders(2017)33 cited
- → Discovery of a series of novel 5H-pyrrolo[2,3-b]pyrazine-2-phenyl ethers, as potent JAK3 kinase inhibitors(2013)32 cited
- → Development of amino-pyrimidine inhibitors of c-Jun N-terminal kinase (JNK): Kinase profiling guided optimization of a 1,2,3-benzotriazole lead(2012)27 cited
- → Novel Series of Dihydropyridinone P2X7 Receptor Antagonists(2015)27 cited
- → Lateral Lithiation Reactions Promoted by Heteroatomic Substituents(1995)26 cited